Identification of Class I HLA T Cell Control Epitopes for West Nile Virus
暂无分享,去创建一个
William H. Hildebrand | C. Rinaldo | Curtis McMurtrey | Wilfried Bardet | W. Hildebrand | P. Piazza | S. Kaabinejadian | K. Jackson | R. Buchli | F. Schafer | S. Cate | Saghar Kaabinejadian | Paolo A. Piazza | Curtis P. McMurtrey | Stephen R. Vernon | Steven J. Cate | Wilfried Bardet | Fredda B. Schafer | Kenneth W. Jackson | Diana M. Campbell | Rico Buchli | Charles R. Rinaldo | D. Campbell | Stephen Vernon
[1] Mario Roederer,et al. Frontline : Polyfunctional T cell responses are a hallmark of HIV-2 infection , 2008 .
[2] Michael S. Diamond,et al. Role of CD8+ T Cells in Control of West Nile Virus Infection , 2004, Journal of Virology.
[3] P. Kloetzel,et al. The base of the proteasome regulatory particle exhibits chaperone-like activity , 1999, Nature Cell Biology.
[4] M. R. Leach,et al. Localization of the Lectin, ERp57 Binding, and Polypeptide Binding Sites of Calnexin and Calreticulin* , 2002, The Journal of Biological Chemistry.
[5] Wilfried Bardet,et al. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery. , 2005, Biochemistry.
[6] W. Hildebrand,et al. Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells , 2006, Expert review of proteomics.
[7] W. Hildebrand,et al. HLA-B15 peptide ligands are preferentially anchored at their C termini. , 1999, Journal of immunology.
[8] Geoffrey Land,et al. Improved Definition of Human Leukocyte Antigen Frequencies Among Minorities and Applicability to Estimates of Transplant Compatibility , 2007, Transplantation.
[9] P. Kloetzel,et al. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. , 2004, Current opinion in immunology.
[10] M. Loeb,et al. Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes , 2008, Proceedings of the National Academy of Sciences.
[11] Farzad Mostashari,et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey , 2001, The Lancet.
[12] J. Wolchok,et al. Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses. , 2009, Cytotherapy.
[13] Mark Lindsey,et al. Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501 , 1997, Immunogenetics.
[14] G. Nybakken,et al. Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus , 2007, Journal of Virology.
[15] Thomas B Kepler,et al. B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study , 2012, Nature Biotechnology.
[16] Muthuraman Sathiamurthy,et al. Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire1 , 2004, The Journal of Immunology.
[17] Michael Engle,et al. A Critical Role for Induced IgM in the Protection against West Nile Virus Infection , 2003, The Journal of experimental medicine.
[18] G. Rimmelzwaan,et al. A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus , 2011, PloS one.
[19] C. Rice,et al. The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response1 , 2009, The Journal of Immunology.
[20] A. Rivas-Estilla,et al. Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico. , 2010, Vector borne and zoonotic diseases.
[21] Catherine M. Brown,et al. The Resurgence of West Nile Virus , 2012, Annals of Internal Medicine.
[22] M. Diamond,et al. Single-Chain HLA-A2 MHC Trimers That Incorporate an Immundominant Peptide Elicit Protective T Cell Immunity against Lethal West Nile Virus Infection , 2010, The Journal of Immunology.
[23] Anders Sjöstedt,et al. Signatures of T Cells as Correlates of Immunity to Francisella tularensis , 2012, PloS one.
[24] R. Lanciotti,et al. Virus and antibody dynamics in acute west nile virus infection. , 2008, The Journal of infectious diseases.
[25] S. Green,et al. Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination. , 2011, The Journal of infectious diseases.
[26] Concepción Marañón,et al. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope , 2003, Nature Immunology.
[27] H. Robinson,et al. T cell vaccines for microbial infections , 2005, Nature Medicine.
[28] D. McDermott,et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection , 2006, The Journal of experimental medicine.
[29] M. Diamond,et al. Recent progress in West Nile virus diagnosis and vaccination , 2012, Veterinary Research.
[30] G. Pantaleo,et al. Functional signatures of protective antiviral T‐cell immunity in human virus infections , 2006, Immunological reviews.
[31] J. Westermann,et al. CD4 memory T cells on trial: immunological memory without a memory T cell. , 2008, Trends in immunology.
[32] M. Loeb,et al. Surface Phenotype and Functionality of WNV Specific T Cells Differ with Age and Disease Severity , 2010, PloS one.
[33] J. Yewdell. Plumbing the sources of endogenous MHC class I peptide ligands. , 2007, Current opinion in immunology.
[34] L. Old,et al. A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples. , 2004, Journal of immunological methods.
[35] Bjoern Peters,et al. Insights into HLA-Restricted T Cell Responses in a Novel Mouse Model of Dengue Virus Infection Point toward New Implications for Vaccine Design , 2011, The Journal of Immunology.
[36] A. Müllbacher,et al. CD8+ T Cells Mediate Recovery andImmunopathology in West Nile VirusEncephalitis , 2003, Journal of Virology.
[37] A. Sette,et al. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. , 2003, Current opinion in immunology.
[38] D. Fremont,et al. The structural immunology of antibody protection against West Nile virus , 2008, Immunological reviews.
[39] T. Ottenhoff,et al. Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection , 2010, European journal of immunology.
[40] N. L. La Gruta,et al. Precursor Frequency and Competition Dictate the HLA-A2–Restricted CD8+ T Cell Responses to Influenza A Infection and Vaccination in HLA-A2.1 Transgenic Mice , 2011, The Journal of Immunology.
[41] H. Kamel,et al. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening , 2009, Transfusion.
[42] J. Neefjes,et al. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling , 1994, The Journal of experimental medicine.
[43] Anantha Marri,et al. B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus , 2003, Journal of Virology.
[44] R. Dwek,et al. Major Histocompatibility Complex Class I Molecules Expressed with Monoglucosylated N-Linked Glycans Bind Calreticulin Independently of Their Assembly Status* , 2004, Journal of Biological Chemistry.
[45] Morten Nielsen,et al. Identification of CD8+ T Cell Epitopes in the West Nile Virus Polyprotein by Reverse-Immunology Using NetCTL , 2010, PloS one.